These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Pholedrine for determining the site of Horner syndrome]. Wilhelm H; Schäffer E Klin Monbl Augenheilkd; 1994 Mar; 204(3):169-75. PubMed ID: 8196303 [TBL] [Abstract][Full Text] [Related]
10. Horner's syndrome. Criteria for oculosympathetic denervation. van der Wiel HL; van Gijn J J Neurol Sci; 1982 Nov; 56(2-3):293-8. PubMed ID: 7175553 [TBL] [Abstract][Full Text] [Related]
11. Localization of Horner's syndrome. Use and limitations of the hydroxyamphetamine test. Van der Wiel HL; Van Gijn J J Neurol Sci; 1983 May; 59(2):229-35. PubMed ID: 6854351 [TBL] [Abstract][Full Text] [Related]
16. Adrenergic mydriasis in Horner's syndrome. Hydroxyamphetamine test for diagnosis of postganglionic defects. Thompson HS; Mensher JH Am J Ophthalmol; 1971 Aug; 72(2):472-80. PubMed ID: 5571230 [No Abstract] [Full Text] [Related]
17. Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome. Bates AT; Chamberlain S; Champion M; Foley L; Hughes E; Jani B; Mehta H; Smith SE J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):215-7. PubMed ID: 7876854 [TBL] [Abstract][Full Text] [Related]
18. The diagnosis of Horner's syndrome. Use and limitations of the cocaine test. Van der Wiel HL; Van Gijn J J Neurol Sci; 1986 May; 73(3):311-6. PubMed ID: 3723131 [TBL] [Abstract][Full Text] [Related]
19. Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Wilhelm H; Ochsner H; Kopycziok E; Trauzettel-Klosinski S; Schiefer U; Zrenner E Ger J Ophthalmol; 1992; 1(2):96-102. PubMed ID: 1477633 [TBL] [Abstract][Full Text] [Related]